Q2 2021 Holdings
Filed 2021-08-16 | 156 holdings | $973.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $141.9M | 2,574,308 | 14.6% |
| Align Technology Inc(ALGN) | COM | 016255101 | $114.7M | 187,750 | 11.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $94.8M | 315,000 | 9.7% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $68.6M | 200,000 | 7.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $66.1M | 3,762,312 | 6.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $50.9M | 300,000 | 5.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $48.2M | 626,100 | 5.0% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $43.9M | 700,000 | 4.5% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $39.8M | 5,248,829 | 4.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $39.3M | 113,500 | 4.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $34.2M | 800,000 | 3.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $30.7M | 233,500 | 3.2% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $27.7M | 1,075,912 | 2.8% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $26.6M | 650,000 | 2.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $24.4M | 1,000,000 | 2.5% |
| Conmed Corp(CNMD) | COM | 207410101 | $22.3M | 162,500 | 2.3% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $21.7M | 920,000 | 2.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $21.2M | 253,500 | 2.2% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $18.2M | 1,165,582 | 1.9% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $17.0M | 791,133 | 1.7% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $10.2M | 785,769 | 1.0% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $6.6M | 1,545,000 | 0.7% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $284.0K | 6,999,023 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $179.5K | 1,014,000 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $133.9K | 302,500 | 0.0% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $113.7K | 180,000 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $112.2K | 408,750 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $110.4K | 120,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $98.8K | 1,015,000 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $96.6K | 455,000 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $96.1K | 240,000 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $93.5K | 2,394,785 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $93.0K | 450,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $88.0K | 531,000 | 0.0% |
| Freshpet Inc(FRPT) | COM | 358039105 | $82.5K | 506,500 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $77.6K | 2,302,032 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $71.1K | 808,860 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $70.9K | 570,000 | 0.0% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $66.1K | 2,151,738 | 0.0% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $62.2K | 1,025,000 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $60.3K | 582,000 | 0.0% |
| Phreesia Inc(PHR) | COM | 71944F106 | $58.8K | 960,000 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $58.5K | 625,000 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $58.0K | 962,826 | 0.0% |
| Eargo Inc | COM | 270087109 | $57.9K | 1,450,000 | 0.0% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $52.2K | 130,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $51.5K | 319,085 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $48.8K | 950,091 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $44.3K | 465,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $44.1K | 386,618 | 0.0% |